June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Changes in qCSF Contrast Sensitivity Following Anti-VEGF Injection in Exudative Age-Related Macular Degeneration
Author Affiliations & Notes
  • Ken Whang
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Grace Baldwin
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Filippos Vingopoulos
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Itika Garg
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Hannah Wescott
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Thomas Koch
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Rebecca Zeng
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Ines Lains
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Jack Tracy
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Joan W Miller
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Deeba Husain
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Demetrios G. Vavvas
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • John B Miller
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Ken Whang None; Grace Baldwin None; Filippos Vingopoulos None; Itika Garg None; Hannah Wescott None; Thomas Koch None; Rebecca Zeng None; Ines Lains None; Jack Tracy None; Joan Miller None; Deeba Husain None; Demetrios Vavvas None; John Miller Alcon, Allergan, Carl Zeiss, Sunovion, Topcon, Genentech, Code C (Consultant/Contractor)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, OD71. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ken Whang, Grace Baldwin, Filippos Vingopoulos, Itika Garg, Hannah Wescott, Thomas Koch, Rebecca Zeng, Ines Lains, Jack Tracy, Joan W Miller, Deeba Husain, Demetrios G. Vavvas, John B Miller; Changes in qCSF Contrast Sensitivity Following Anti-VEGF Injection in Exudative Age-Related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2023;64(8):OD71.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The purpose of our study is to evaluate changes in contrast sensitivity (CS) with the Quantitative CS Function (qCSF) test (Adaptive Sensory Technology), a robust CS evaluation that assesses visual function across multiple spatial frequencies, in nontreatment-naïve eyes with exudative age related macular degeneration (AMD) before and after intravitreal anti-VEGF injections.

Methods : This cross-sectional prospectively recruited observational study included 22 eyes of 14 patients with nontreatment-naive exudative AMD tested for CS with the qCSF test from July 2018 to July 2022. Functional outcomes included Snellen VA, and the following qCSF metrics: Area under the Log CSF (AULCSF), contrast acuity (CA), and CS thresholds at 1 to 18 cycles per degree (cpd). Paired T-tests were used to evaluate changes in visual function outcomes after injection. Statistical significance was set at p-value less than 0.05.

Results : In our AMD cohort, the median logMAR VA before intravitreal anti-VEGF injection was 0.239 (Snellen equivalent: 20/35) and after a single injection was improved at 0.226 (Snellen equivalent: 20/34), which was not statistically significantly different on pairwise comparison (p = 0.89). Among the CS metrics however, CS at 6 cpd was found to be statistically significantly improved after 1 intravitreal anti-VEGF injection (0.503 vs. 0.673, p = 0.007), while the other CS metrics were not significantly different. In a subset of 13 eyes of 11 patients with a decrease or no change in logMAR VA after 1 injection, CS at 6 cpd and AULSCF were able to still show statistically significant improvements, (0.584 vs. 0.676, p =0.033) and (0.710 vs. 0.714, p = 0.034) respectively.

Conclusions : Our results demonstrated that among eyes with nontreatment-naive exudative AMD, intravitreal anti-VEGF injection was associated with statistically significant improvements in contrast sensitivity, even when VA did not show a significant improvement. Across the various qCSF outcomes tested, CS at 6 cpd and AULCSF may be most sensitive to changes associated with intravitreal anti-VEGF injection which is consistent with prior published results. CS evaluation with the qCSF test is a useful adjunct functional metric that may impact the clinical decision making on whether to continue anti-VEGF injections among nontreatment-naïve eyes with AMD and other retinal diseases, even when VA has plateaued.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×